Dynavax Technologies Corporation (DVAX)

18.98
0.86 4.70
NASDAQ
Prev Close 18.12
Open 18.00
Day Low/High 17.86 / 18.85
52 Wk Low/High 3.58 / 20.96
Volume 348.64K
Exchange NASDAQ
Shares Outstanding 114.76B
Market Cap 2.16B
P/E Ratio N/A
Div & Yield N.A. (N.A)
These 4 Small Biotechs Have Big Upcoming Catalysts

These 4 Small Biotechs Have Big Upcoming Catalysts

Zogenix, Flexion, Dynavax and Progenics all have potential upside on these events.

4 Small Biotechs With Big Catalysts

4 Small Biotechs With Big Catalysts

Zogenix, Flexion, Dynavax and Progenics all have potential upside on upcoming events.

Not Much Shakin', but Here Are 3 Stocks to Check Out

Not much in the way of trading action to begin the new week. All indices are down slightly an hour into trading this Monday. Individual names are moving on company-specific news and analyst commentary. Oil continues to show strength to start the wee...

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

Small-Cap Turnaround Stories

Small-Cap Turnaround Stories

When one of these pays off, it can make up for a number of errant wagers.

Oil Has Solid Day; Dynavax Drug Appears Close to Approval

Thanks to all who participated in the Daily Diary today. Market was listless and traded in a small range all day, but conversation was very lively. Market indices end week slightly down in directionless trading. Oil has solid day and is back near $5...

Gilead Solidly Higher; Markets in Narrow Range

Markets continue to trade in a very narrow range this Friday, commentary on the Daily Diary is certainly more active than equities today! Most major indices remain slightly down as they have been pretty much since the opening bell. The Dow has just ...

Voya, Synchrony Still Benefitting From Rising Rates

Markets have not changed much since our last update 90 minutes ago. Indices slightly down across the board in pretty listless trading so far. Markets look set to close out with minor losses for the week this Friday. Biotech continues to recoup some ...

Now Up to the Plate, Today's Pinch Hitter, Bret Jensen!

It is good to be sitting in for Doug Kass here on the Daily Diary as we look to end the trading week on a positive note. It is also good to see the Yankees start to win close games again after losing so many of them in the weeks leading into the All...

Navigate Choppy Investment Waters With Good Trade Management

Navigate Choppy Investment Waters With Good Trade Management

The inconsistency makes stock picking difficult, but there are buying opportunities because of it.

3 Biotech Stocks on Readers' Minds

3 Biotech Stocks on Readers' Minds

We answer questions about BioDelivery Sciences, Dynavax Technologies and Synergy Pharmaceuticals.

3 Small Biotechs on the FDA Summer Calendar

3 Small Biotechs on the FDA Summer Calendar

Dynavax Technologies, Ocular Therapeutix and Neos Therapeutics have big drug approval dates ahead.

Biotech Stocks Finally Stage Breakthrough

Biotech Stocks Finally Stage Breakthrough

The sector decisively has pushed through upward resistance levels in place for many months.

4 Undervalued Biotech Stocks

4 Undervalued Biotech Stocks

Two are turnaround stories, and two are oversold.

Biotech Needs a Shot in the Arm

Biotech Needs a Shot in the Arm

But there is hope, as the FDA has approved almost as many new compounds in 2017 as in all of 2016.

Biotech Needs a Shot in the Arm

Biotech Needs a Shot in the Arm

But there is hope, as the FDA has approved almost as many new compounds in 2017 as in all of 2016.

2 Questions From the Biotech Mailbag

2 Questions From the Biotech Mailbag

A look at how lawsuits and FDA changes could impact the industry.

Could These 9 Drugs Gain FDA Approval in the Age of Trump?

Could These 9 Drugs Gain FDA Approval in the Age of Trump?

Nine biotech and drug companies want FDA approval, but need changed standards to get it.

The 'Gnarly 9' Biotechs Will Test the FDA's Mettle

The 'Gnarly 9' Biotechs Will Test the FDA's Mettle

The firms all have drugs they want the feds to bend the rules to approve.

4 Smaller Biotech Names Worth Researching

4 Smaller Biotech Names Worth Researching

Here's why to check out Dynavax Technologies as well Lexicon, Supernus and Acadia Pharmaceuticals.

My Top 2017 Pick: Progenics Pharmaceuticals

My Top 2017 Pick: Progenics Pharmaceuticals

This biopharma company's Relistor drug should send revenues sharply higher this year.

Top 2017 Pick: Progenics Pharmaceuticals

Top 2017 Pick: Progenics Pharmaceuticals

This biopharma company's Relistor drug should send revenues sharply higher next year.

Dynavax Shares Plunge on Rejected Application

Dynavax Shares Plunge on Rejected Application

Shares of the drugmaker were falling on news that U.S. regulators have rejected its Heplisav-B application

Midday Report: Dynavax Slumps on FDA Rejection; U.S. Stocks Fluctuate

Midday Report: Dynavax Slumps on FDA Rejection; U.S. Stocks Fluctuate

U.S. stocks fluctuate as Wall Street picks apart the likely policies of President-elect Donald Trump.

4 Biotechs Set to Provide a Shot in the Arm

4 Biotechs Set to Provide a Shot in the Arm

Each company has approaching catalysts.

4 Biotechs Set to Provide a Shot in the Arm

4 Biotechs Set to Provide a Shot in the Arm

Each company has approaching catalysts.

How to Play It When the FDA Slams Your Stock

How to Play It When the FDA Slams Your Stock

Here are three recent examples of how the patient can profit.

5 Small-Cap Biotechs With Big Potential

5 Small-Cap Biotechs With Big Potential

These 5 stocks all have positive catalysts on the horizon.

5 Small-Cap Biotechs With Big Potential

5 Small-Cap Biotechs With Big Potential

These 5 stocks all have positive catalysts on the horizon.